Insight

Max Servin-Rojas: Lymph Node Yield is in Node-Negative Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy

Photo taken from Max Servin-Rojas/X

Jul 5, 2024, 13:14

Max Servin-Rojas: Lymph Node Yield is in Node-Negative Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy

Max Servin-Rojas, General Surgery Resident at Utah General Surgery Residency, shared a post on X:

“Feeling honored to be published as a first author in the Annals of Surgery.

Deeply grateful to my mentor Motaz Qadan and the rest of the team Zhi Ven Fong, Gabriella Lionetto, Dario Rocha Castellanos (many missing) who made this possible.”

Proceed to the study.
Source: Max Servin-Rojas/X

Annals of Surgery cancer Dario Rocha Castellanos Gabriella Lionetto Lymph Node Yield Max Servin-Rojas Motaz Qadan neoadjuvant therapy OncoDaily Oncology Pancreatic Ductal Adenocarcinom Utah General Surgery Residency Zhi Ven Fong

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage